439 related articles for article (PubMed ID: 24830383)
21. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
22. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
[TBL] [Abstract][Full Text] [Related]
23. Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways.
Libri DV; Kleinau G; Vezzoli V; Busnelli M; Guizzardi F; Sinisi AA; Pincelli AI; Mancini A; Russo G; Beck-Peccoz P; Loche S; Crivellaro C; Maghnie M; Krausz C; Persani L; Bonomi M;
J Clin Endocrinol Metab; 2014 Mar; 99(3):E458-63. PubMed ID: 24276467
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.
Gyombolai P; Tóth AD; Tímár D; Turu G; Hunyady L
J Mol Endocrinol; 2015 Feb; 54(1):75-89. PubMed ID: 25510402
[TBL] [Abstract][Full Text] [Related]
25. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
26. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
Leduc M; Breton B; Galés C; Le Gouill C; Bouvier M; Chemtob S; Heveker N
J Pharmacol Exp Ther; 2009 Oct; 331(1):297-307. PubMed ID: 19584306
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
28. Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation.
Hansen JL; Theilade J; Haunsø S; Sheikh SP
J Biol Chem; 2004 Jun; 279(23):24108-15. PubMed ID: 15056658
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory receptor switch from Gαs to Gαi signaling by β-arrestin-mediated PDE4 recruitment in mixed RA synovial cells.
Jenei-Lanzl Z; Zwingenberg J; Lowin T; Anders S; Straub RH
Brain Behav Immun; 2015 Nov; 50():266-274. PubMed ID: 26212359
[TBL] [Abstract][Full Text] [Related]
30. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.
Griffin MT; Figueroa KW; Liller S; Ehlert FJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):1193-207. PubMed ID: 17392404
[TBL] [Abstract][Full Text] [Related]
31. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
32. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
[TBL] [Abstract][Full Text] [Related]
33. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
[TBL] [Abstract][Full Text] [Related]
34. G protein betagamma11 complex translocation is induced by Gi, Gq and Gs coupling receptors and is regulated by the alpha subunit type.
Azpiazu I; Akgoz M; Kalyanaraman V; Gautam N
Cell Signal; 2006 Aug; 18(8):1190-200. PubMed ID: 16242307
[TBL] [Abstract][Full Text] [Related]
35. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
36. Functional evidence for biased inhibition of G protein signaling by YM-254890 in human coronary artery endothelial cells.
Peng Q; Alqahtani S; Nasrullah MZA; Shen J
Eur J Pharmacol; 2021 Jan; 891():173706. PubMed ID: 33152337
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity.
Domazet I; Holleran BJ; Richard A; Vandenberghe C; Lavigne P; Escher E; Leduc R; Guillemette G
Mol Pharmacol; 2015 Jun; 87(6):982-95. PubMed ID: 25808928
[TBL] [Abstract][Full Text] [Related]
38. Selective regulation of recombinantly expressed mGlu7 metabotropic glutamate receptors by G protein-coupled receptor kinases and arrestins.
Iacovelli L; Felicioni M; Nisticò R; Nicoletti F; De Blasi A
Neuropharmacology; 2014 Feb; 77():303-12. PubMed ID: 24148810
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
40. The C-terminal domain of the Gs-coupled EP4 receptor confers agonist-dependent coupling control to Gi but no coupling to Gs in a receptor hybrid with the Gi-coupled EP3 receptor.
Neuschäfer-Rube F; Hänecke K; Blaschke V; Jungermann K; Püschel GP
FEBS Lett; 1997 Jan; 401(2-3):185-90. PubMed ID: 9013884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
